Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSCW) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $17338.0.

  • Ensysce Biosciences' Non Operating Income rose 185.04% to $17338.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $72342.0, marking a year-over-year increase of 10447.22%. This contributed to the annual value of -$1.3 million for FY2024, which is 146747.65% down from last year.
  • Ensysce Biosciences' Non Operating Income amounted to $17338.0 in Q3 2025, which was up 185.04% from $21011.0 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Non Operating Income registered a high of $3.9 million during Q1 2022, and its lowest value of -$8.0 million during Q4 2021.
  • Moreover, its 5-year median value for Non Operating Income was $12054.0 (2024), whereas its average is -$541785.2.
  • Over the last 5 years, Ensysce Biosciences' Non Operating Income had its largest YoY gain of 109424.11% in 2022, and its largest YoY loss of 108084.04% in 2022.
  • Over the past 5 years, Ensysce Biosciences' Non Operating Income (Quarter) stood at -$8.0 million in 2021, then skyrocketed by 109.89% to $794523.0 in 2022, then plummeted by 143.88% to -$348676.0 in 2023, then surged by 103.46% to $12054.0 in 2024, then soared by 43.84% to $17338.0 in 2025.
  • Its last three reported values are $17338.0 in Q3 2025, $21011.0 for Q2 2025, and $21939.0 during Q1 2025.